While some forms of the disease respond well to treatment, others are stubborn and aggressive.
The doctor says the next step is to put MI-2 into pill form, and test it on people who have aggressive forms of non-hodgkins lymphoma.
If treatment is successful in those trials, the drug therapy could possibly help treat other forms of lymphoma, as well as a variety of inflammatory and autoimmune disorders.
